COVID-19 Research Coordination & Learning



The newly formed initiative COVID CIRCLE – COVID-19 Research Coordination and Learning – is a partnership between UKCDR and the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).

COVID CIRCLE will harness current UKCDR and GloPID-R activities, including continual mapping and analysis of global COVID-19 funding through our COVID Tracker. Building on this work, COVID CIRCLE will coordinate funding efforts, connect networks of researchers, and collate learnings to inform future epidemic and pandemic responses with a focus on lower-resource settings.

“Research is crucial to helping the world overcome the COVID-19 pandemic. The work of COVID CIRCLE provides critical coherence for funding research to tackle COVID-19 now, as well as help for epidemics and pandemics for the future.” 

– Prof Peter Piot, Chair of Strategic Coherence for ODA Research (SCOR) Board and UKCDR.

COVID-19 Research Project Tracker

This is a live database of funded research projects across the world related to the current COVID-19 pandemic. By providing an overview of research projects mappedagainst the priorities identified in the WHO Coordinated Global Research Roadmap: 2019 Novel Coronavirus, we aim to support funders and researchers deliver a more effective and coherent global research response.

  • About UKCDR & GloPID-R

    About UKCDR

    The UK Collaborative on Development Research (UKCDR) is a group of UK government departments and research funders working in international development research.

    UKCDR exists to amplify the value and impact of research for global development by promoting coherence, collaboration and joint action among UK research funders. governed by the Strategic Coherence of ODA-funded Research (SCOR) Board.

    About GloPID-R

    GloPID-R is a network of funding organizations investing in infectious diseases research preparedness and response.

    GloPID-R is the only alliance of its kind to bring together research funding organizations on a global scale to facilitate an effective and rapid research of a significant outbreak of a new or re-emerging infectious disease with epidemic and pandemic potential.